A Multicenter, Non-Randomized, Open Label Trial Of Azithromycin SR For The Treatment Of Acute Bronchitis And Secondary Infection Of Chronic Respiratory Diseases In Japan Adults.

Trial Profile

A Multicenter, Non-Randomized, Open Label Trial Of Azithromycin SR For The Treatment Of Acute Bronchitis And Secondary Infection Of Chronic Respiratory Diseases In Japan Adults.

Completed
Phase of Trial: Phase III

Latest Information Update: 20 Apr 2011

At a glance

  • Drugs Azithromycin (Primary)
  • Indications Acute bronchitis; Bacterial infections; Respiratory tract infections
  • Focus Therapeutic Use
  • Sponsors Pfizer
  • Most Recent Events

    • 20 Apr 2011 Actual end date (Jun 2007) added as reported by ClinicalTrials.gov.
    • 08 May 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top